Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Virology|March 25, 2016
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman PrimatesRoger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, et al.
NPJ Vaccines|August 18, 2021
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimersKwinten Sliepen, Edith Schermer, Ilja Bontjer, et al.
Journal of Clinical Immunology|January 9, 2022
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC NeutralizationStefania Dispinseri, Ilaria Marzinotto, Cristina Brigatti, et al.
Nature Communications|May 12, 2021
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalStefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, et al.
Plos One|May 17, 2012
International network for comparison of HIV neutralization assays: the NeutNet report IILeo Heyndrickx, Alan Heath, Enas Sheik-Khalil, et al.
Cell Reports. Medicine|September 27, 2022
Innate cell markers that predict anti-HIV neutralizing antibody titers in vaccinated macaquesMatthieu Van Tilbeurgh, Pauline Maisonnasse, Jean-Louis Palgen, et al.
Frontiers in Immunology|May 23, 2022
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate ModelClaire-Maëlle Fovet, Camille Pimienta, Mathilde Galhaut, et al.
NPJ Vaccines|July 14, 2023
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigensGregory M Martin, Rebecca A Russell, Philip Mundsperger, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
Human Gene Therapy|July 21, 2018
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope VaccineHannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, et al.
Pageof 3